SCHEMBL15733367

SCHEMBL15733367

Cc1cccc(C(=O)OCCOC(=O)c2cccc(C)c2N)c1N

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.67
CYP19A1 P11511 1/20 0.67
CYP2C9 P11712 1/20 0.67
CYP2C19 P33261 1/20 0.67
TSHR P16473 6/20 0.53
ALDH1A1 P00352 7/20 0.50
HSD17B10 Q99714 5/20 0.50
NPC1 O15118 4/20 0.49
RAB9A P51151 4/20 0.49
TDP1 Q9NUW8 3/20 0.49
HPGD P15428 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
TP53 P04637 2/20 0.49
CYP3A4 P08684 2/20 0.49
MAPK1 P28482 2/20 0.49
GLA P06280 1/20 0.49
HIF1A Q16665 1/20 0.49
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15733211 0.94 TSHR (0.65) CYP2D6CYP19A1CYP2C9CYP2C19TSHR
SCHEMBL19994754 0.92 ALDH1A1 (0.64) CYP2D6CYP19A1CYP2C9CYP2C19TSHR
SCHEMBL15733096 0.92 CYP2D6 (0.59) CYP2D6CYP19A1CYP2C9CYP2C19TSHR
SCHEMBL5808886 0.89 ALDH1A1 (0.64) CYP2D6CYP19A1CYP2C9CYP2C19TSHR
SCHEMBL11332129 0.89 CYP2D6 (0.56) CYP2D6CYP19A1CYP2C9CYP2C19TSHR
SCHEMBL27519835 0.89 ALDH1A1 (0.66) CYP2D6CYP19A1CYP2C9CYP2C19TSHR
SCHEMBL28589777 0.88 CYP2D6 (0.55) CYP2D6CYP19A1CYP2C9CYP2C19TSHR
SCHEMBL14645882 0.88 TSHR (0.67) CYP2D6CYP19A1CYP2C9CYP2C19TSHR
SCHEMBL14645636 0.86 ALDH1A1 (0.68) CYP2D6CYP19A1CYP2C9CYP2C19TSHR
SCHEMBL28280218 0.86 ALDH1A1 (0.68) CYP2D6CYP19A1CYP2C9CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169198-B2 Method for the production of 2-amino-5-cyano-N,3-dimethylbenzamide BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-10-27 US disclosed
US-20140148611-A1 METHOD FOR THE PRODUCTION OF 2-AMINO-5-CYANO-N,3-DIMETHYLBENZAMIDE BAYER INTELLECTUAL PROPERTY GMBH (DE) 2014-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140148611-A1 METHOD FOR THE PRODUCTION OF 2-AMINO-5-CYANO-N,3-DIMETHYLBENZAMIDE ALKBH5, ALKBH2, MMAB CYP2D6 443/4885CYP19A1 1729/4885CYP2C9 302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.